BACITRACIN ZINC AND POLYMYXIN B SULFATE ointment United States - English - NLM (National Library of Medicine)

bacitracin zinc and polymyxin b sulfate ointment

e. fougera & co., a division of nycomed us inc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin zinc 500 in 1 g - bacitracin zinc and polymyxin b sulfate ophthalmic ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. bacitracin zinc and polymyxin b sulfate ophthalmic ointment is contraindicated in individuals who have shown hypersensitivity to any of its components.

BACITRACIN ZINC AND POLYMYXIN B SULFATE ointment United States - English - NLM (National Library of Medicine)

bacitracin zinc and polymyxin b sulfate ointment

stat rx usa llc - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin zinc 500 [usp'u] in 1 g - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin b sulfate. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

BACITRACIN ZINC AND POLYMYXIN B SULFATE ointment United States - English - NLM (National Library of Medicine)

bacitracin zinc and polymyxin b sulfate ointment

physicians total care, inc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin zinc 500 [usp'u] in 1 g - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin b sulfate. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

BACITRACIN ZINC AND POLYMYXIN B SULFATE ointment United States - English - NLM (National Library of Medicine)

bacitracin zinc and polymyxin b sulfate ointment

bausch & lomb incorporated - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin 500 [usp'u] in 1 g - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin b sulfate. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

BACITRACIN ZINC AND POLYMYXIN B SULFATE ointment United States - English - NLM (National Library of Medicine)

bacitracin zinc and polymyxin b sulfate ointment

rebel distributors corp. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin zinc 500 [usp'u] in 1 g - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin b sulfate. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

BACITRACIN injection United States - English - NLM (National Library of Medicine)

bacitracin injection

xellia pharmaceuticals aps - bacitracin (unii: 58h6rwo52i) (bacitracin - unii:58h6rwo52i) - bacitracin 50000 [iu] - in accordance with the statements in the “warning box” the use of intramuscular bacitracin is limited to the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug. to reduce the development of drug-resistant bacteria and maintain the effectiveness of bacitracin and other antibacterial drugs, bacitracin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in those individuals with a history of previous hypersensitivity or toxic reaction to it.

Bacitracin for Injection, USP United States - English - NLM (National Library of Medicine)

bacitracin for injection, usp

pharmacia and upjohn company - bacitracin a (unii: dda3rrx0p7) (bacitracin a - unii:dda3rrx0p7) - bacitracin a 5000 [usp'u] in 1 ml - in accordance with the statements in the "warning box", the use of intramuscular bacitracin is limited to the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug. to reduce the development of drug-resistant bacteria and maintain the effectiveness of bacitracin and other antibacterial drugs, bacitracin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in those individuals with a history of previous hypersensitivity or toxic reaction to it.

BACITRACIN- bacitracin injection, powder, lyophilized, for solution United States - English - NLM (National Library of Medicine)

bacitracin- bacitracin injection, powder, lyophilized, for solution

x-gen pharmaceuticals, inc. - bacitracin (unii: 58h6rwo52i) (bacitracin - unii:58h6rwo52i) - bacitracin 50000 [usp'u] - in accordance with the statements in the “warning box” the use of intramuscular bacitracin is limited to the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug. to reduce the development of drug-resistant bacteria and maintain the effectiveness of bacitracin and other antibacterial drugs, bacitracin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in those individuals with a history of previous hypersensitivity or toxic reaction to it.

BACITRACIN ZINC AND POLYMYXIN B SULFATE ointment United States - English - NLM (National Library of Medicine)

bacitracin zinc and polymyxin b sulfate ointment

rebel distributors corp - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin zinc 500 in 1 g - this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

BACITRACIN USP POWDER FOR SOLUTION Canada - English - Health Canada

bacitracin usp powder for solution

pfizer canada ulc - bacitracin - powder for solution - 50000unit - bacitracin 50000unit - bacitracins